|
2024
|
Invention
|
In vivo use. Stable liquid formulation for interleukin-2 (IL-2), interleukin-7 (IL-7), interleuki... |
|
|
Invention
|
Ex vivo use. ex vivoex vivo use are provided. |
|
2023
|
Invention
|
Treatment for retinal disorders. Compositions in the treatment of retinal disorders include a pho... |
|
2021
|
Invention
|
Novel preventive and therapeutic treatment for covid 19 and any other disease caused by sars cov ... |
|
|
Invention
|
Delivery of aerosolized micromolar composition concentrations.
Formulations and pressurized devi... |
|
|
Invention
|
Delivery of aerosolized micromolar composition concentrations. Formulations and pressurized devic... |
|
|
Invention
|
Preventive and therapeutic treatment for covid 19 and any other disease caused by sars cov 2. Nov... |
|
2020
|
Invention
|
Therapeutically active aldesleukin highly stable in liquid pharmaceutical compositions. The... |
